 |
Drug Diversion Insights with Terri VidalsAuthor: Terri Vidals
For everyone in the healthcare industry looking to reduce substance abuse and drug diversion. The host, Terri Vidals, is a pharmacist with over 30 years of experience; fifteen of those years in medication safety and drug diversion prevention and monitoring. Listen to an interview each week with a healthcare professional involved in diversion detection. Learn about how to leverage artificial intelligence to detect diversion and get exposure to products or services designed to facilitate diversion detection. Language: en Genres: Health & Fitness, Mental Health Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Buprenorphine Unfiltered: Efficacy, Discontinuation, and Post-Acute Withdrawal
Wednesday, 18 February, 2026
Few medications in addiction treatment generate as much debate as buprenorphine.After receiving significant listener feedback describing difficult experiences with this medication—particularly around discontinuation—Terri sits down with returning guest Dr. Stuart Gitlow for a candid, science-based discussion about one of the most widely used treatments for opioid use disorder.In this episode, we explore:• The science behind medication for opioid use disorder (MOUD)• Why buprenorphine has helped many patients• Reported challenges with tapering and discontinuation• Post-acute withdrawal symptoms (PAWS)• The importance of informed consent and realistic expectationsThis conversation does not dismiss patient experiences, nor does it ignore the life-saving role buprenorphine has played in recovery. Instead, it brings nuance to a complex issue—balancing clinical evidence with lived experience.Whether you are a provider, patient, policymaker, or simply interested in addiction medicine, this episode offers thoughtful insight into efficacy, expectations, and long-term outcomes.More from Rxpert Solutions: https://www.rxpert.solutions/?utm_source=spotify&utm_medium=insights&utm_campaign=buprenorphine
